.Basilea Pharmaceutica's work cultivating brand-new antifungals has actually obtained a notable impr...
.Possessing actually gathered up the U.S. legal rights to Capricor Therapies' late-stage Duchenne mu...
.After pushing the selection date for Applied Therapeutics' metabolic disorder drug govorestat, the ...
.Novo Nordisk is continuing its own push into hereditary medications, agreeing to pay NanoVation The...
.Innovent Biologics has helped make the case that its own checkpoint inhibitor-cytokine combination ...
.A period 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...
.5 months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotech h...
.Ascendis Pharma has emerged as a potential hazard to BioMarin's Voxzogo, disclosing period 3 develo...
.Though Alkeus Pharmaceuticals' oral eye health condition property failed to significantly lower geo...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually very easy to overlook ...
.Invulnerable gate inhibitors are actually the superheroes of cancer treatment. Medicines like Brist...
.Invite to today's Chutes & Ladders, our summary of considerable management hirings, shootings as...
.Regeneron is actually back with long-lasting follow-up for its LAG-3 inhibitor as well as PD-1 prev...
.AstraZeneca has discussed an early examine the efficiency of its in-house antibody-drug conjugate (...
.After introducing a period 3 launch based upon positive midstage results, iTeos and also GSK are ac...
.The FDA should be even more available as well as collaborative to release a rise in approvals of un...
.It's an unusually occupied Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Reh...
.Atea Pharmaceuticals' antiviral has neglected an additional COVID-19 trial, yet the biotech still s...
.Neurocrine Biosciences' mental illness course pivot has stopped working. The biotech was not able t...
.Sanofi has made a late entry to the radioligand celebration, paying out 100 thousand euros ($ 110 t...